Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twelve research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month […]
Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its target price boosted by Robert W. Baird from $52.00 to $62.00 in a research report sent to investors on Thursday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other equities research analysts also recently weighed in on CRNX. Morgan Stanley upped […]
Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They presently have a $60.00 price target on the stock. HC Wainwright’s price objective points to a potential upside of 18.72% from the stock’s previous […]
Crinetics Pharmaceuticals (NASDAQ:CRNX) Rating Reiterated by JMP Securities tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Richard Scott Struthers Sells 40,951 Shares of Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.